Astrotech Corporation (NASDAQ:ASTC – Get Free Report) was the target of a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 75,943 shares, a growth of 95.2% from the April 15th total of 38,911 shares. Based on an average trading volume of 129,737 shares, the short-interest ratio is currently 0.6 days. Approximately 5.2% of the shares of the company are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings cut shares of Astrotech from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Friday, April 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.
View Our Latest Research Report on Astrotech
Astrotech Stock Performance
Astrotech (NASDAQ:ASTC – Get Free Report) last posted its earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. The firm had revenue of $0.34 million for the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%.
Institutional Investors Weigh In On Astrotech
A number of large investors have recently made changes to their positions in ASTC. Susquehanna International Group LLP purchased a new stake in Astrotech during the 3rd quarter worth approximately $66,000. DRW Securities LLC increased its stake in Astrotech by 168.5% during the 4th quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock worth $109,000 after buying an additional 19,747 shares during the period. Finally, J. Safra Sarasin Holding AG purchased a new stake in Astrotech during the 1st quarter worth approximately $140,000. 24.35% of the stock is currently owned by hedge funds and other institutional investors.
About Astrotech
Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.
In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.
Featured Articles
- Five stocks we like better than Astrotech
- Consumer-Driven Stocks Boost Buybacks, Including Visa’s $20B Plan
- Iran Ceasefire Trade: 3 Energy Stocks to Own if Oil Falls to $80
- Willing and Abel: Berkshire’s New CEO Makes Huge Portfolio Changes in Q1
- Insider Buying Says Upstart Isn’t Down for the Count
Receive News & Ratings for Astrotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrotech and related companies with MarketBeat.com's FREE daily email newsletter.
